Eidos Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 28.241 million compared to USD 14.794 million a year ago. Net loss was USD 28.849 million compared to USD 14.053 million a year ago. For the half year, operating loss was USD 51.127 million compared to USD 27.378 million a year ago. Net loss was USD 51.673 million compared to USD 25.786 million a year ago.